justbacked

Biotechnology, Clinical Trials, Oncology, Pharmaceutical

AdvanCell

AdvanCell develops targeted alpha radiopharmaceutical therapies for cancer and supports their development and manufacturing.

Series D · $315M · 84d agoadvancell.com.au

Hiring velocity

Open roles
10
Added, 30 days
+4
Added, 7 days
+0
Closed, 30 days
7
Raised
84 days ago
Led by
Eli Lilly, Alpha Wave Global, Catalio Capital Management, Bain Capital Life Sciences, SV Health Investors
Team size
51-100
HQ
Sydney, New South Wales, Australia
Newest role
18d ago
Tracked since
Aug 21, 2026

Where they're hiring

Operations3
Hardware2
Clinical1

Open roles at AdvanCell

$315M · 84d ago

AdvanCell · Series D

US Site Quality Lead

Andover, MA

$175K–$250K

Posted 20 days ago· Sep 16

HardwareLed by Eli Lilly, Alpha Wave Global
$315M · 84d ago

AdvanCell · Series D

Director of Facilities

Richlands, Brisbane, QLD, AU

Posted 97 days ago· Jul 1

OperationsLed by Eli Lilly, Alpha Wave Global

Source: jobs.lever.co, checked daily.